50 related articles for article (PubMed ID: 34786910)
1. [Active surgical approach for retroperitoneal liposarcoma].
Volkov AY; Nered SN; Kozlov NA; Stilidi IS; Archery PP; Antonova EY; Privezentsev SA
Khirurgiia (Mosk); 2021; (11):5-11. PubMed ID: 34786910
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant Palbociclib May be Associated with Delayed Recurrence in Completely Resected Retroperitoneal Liposarcoma: Results of a Single-Institution Retrospective Cohort Study.
Selby LV; Clark EC; Liebner DA; Chen JL; Tinoco G; Bashian E; Beane JD; Pollock RE; Grignol VP
Ann Surg Oncol; 2023 Nov; 30(12):7876-7881. PubMed ID: 37330448
[TBL] [Abstract][Full Text] [Related]
3. Clinical and surgical effectiveness of the multi-disciplinary standardized management model in the treatment of retroperitoneal liposarcoma: Evidence-based clinical practice experience from Fudan Zhongshan.
Fan P; Tao P; Wang J; Wang Z; Hou Y; Zhou Y; Lu W; Ma L; Zhang Y; Tong H
Surgery; 2024 May; 175(5):1368-1376. PubMed ID: 38395638
[TBL] [Abstract][Full Text] [Related]
4. Identification of predictors for short-term recurrence: comprehensive analysis of 296 retroperitoneal liposarcoma cases.
Yu Z; Li R; Yuan Z; Ye J; He P; Li P; Sun Y; Zhao X
World J Surg Oncol; 2024 Feb; 22(1):46. PubMed ID: 38321480
[TBL] [Abstract][Full Text] [Related]
5. Predictors and outcomes of recurrent retroperitoneal liposarcoma: new insights into its recurrence patterns.
Deng H; Gao J; Xu X; Liu G; Song L; Pan Y; Wei B
BMC Cancer; 2023 Nov; 23(1):1076. PubMed ID: 37936091
[TBL] [Abstract][Full Text] [Related]
6. Analysis of recurrence and metastasis patterns and prognosis after complete resection of retroperitoneal liposarcoma.
Gao X; Ding P; Zhang Z; Li Y; Zhao Q; Wang D; Zhao X; Liu Y; Tan B
Front Oncol; 2023; 13():1273169. PubMed ID: 38188302
[TBL] [Abstract][Full Text] [Related]
7. Gender Differences in Prognosis After Primary Resection for Retroperitoneal Liposarcoma.
Ren L; Qi Y; Zhao J; Weng C; Wang J; Yuan D; Wang T
Am Surg; 2024 Apr; 90(4):575-584. PubMed ID: 37728273
[TBL] [Abstract][Full Text] [Related]
8. TNM classification of malignant tumors: Eighth edition for retroperitoneal liposarcoma. Ways to improve.
Nered SN; Volkov AY; Kozlov NA; Stilidi IS; Arhiri PP
Asia Pac J Clin Oncol; 2023 Oct; 19(5):e267-e272. PubMed ID: 36385584
[TBL] [Abstract][Full Text] [Related]
9. Retroperitoneal Liposarcoma: Rational Extent of Surgery Tailored to Grade of Malignancy.
Volkov AY; Nered SN; Kozlov NA; Stilidi IS; Arhiri PP; Antonova EY
Indian J Surg Oncol; 2024 Mar; 15(Suppl 1):38-44. PubMed ID: 38545578
[TBL] [Abstract][Full Text] [Related]
10. Comparing Multivisceral Resection with Tumor-only Resection of Liposarcoma Using the Win Ratio.
Gorji L; Nikahd M; Onuma A; Tsilimigras D; Madison Hyer J; Ruff S; Ilyas FZ; Contreras C; Grignol VP; Kim A; Pollock R; Pawlik TM; Beane JD
Ann Surg Oncol; 2024 May; 31(5):3389-3396. PubMed ID: 38347333
[TBL] [Abstract][Full Text] [Related]
11. [Organ infiltration and risk of recurrence after multivisceral resection for primary retroperitoneal liposarcoma].
Yang C; Reissfelder C; Jakob J
Chirurgie (Heidelb); 2023 Jul; 94(7):646-647. PubMed ID: 37318547
[No Abstract] [Full Text] [Related]
12. Surgical treatment of retroperitoneal liposarcoma.
Ikeguchi M; Urushibara S; Shimoda R; Saito H; Wakatsuki T
Yonago Acta Med; 2014 Dec; 57(4):129-32. PubMed ID: 25901099
[TBL] [Abstract][Full Text] [Related]
13. Multifocal retroperitoneal sarcoma.
Theodosopoulos T; Dellaportas D; Psychogiou V; Yiallourou A; Polymeneas G; Gkiokas G; Voros D
Case Rep Surg; 2013; 2013():763702. PubMed ID: 23738184
[TBL] [Abstract][Full Text] [Related]
14. Analysis of potential risk factors in the survival of patients with primary retroperitoneal liposarcoma.
Bianchi A; Pagan-Pomar A; Ramos-Asensio R; Luna-Fra P; Jiménez-Segovia M; Pujol-Cano N; Ochogavia-Seguí A; Martínez-Corcoles JA; González-Argenté FX
Cir Esp (Engl Ed); 2021 Sep; ():. PubMed ID: 34507818
[TBL] [Abstract][Full Text] [Related]
15. A patient with retroperitoneal liposarcoma.
Xu J; Wang F; Liu J; Ma S
Asian J Surg; 2024 Feb; 47(2):1019-1020. PubMed ID: 37985323
[No Abstract] [Full Text] [Related]
16. Overexpression of ASPH protein predicts poor outcomes in retroperitoneal liposarcoma patients.
Xiao M; Chen X; Chen W; Wang L; Rao X; Luo C
Chin Med J (Engl); 2023 Sep; 136(17):2113-2115. PubMed ID: 36897757
[No Abstract] [Full Text] [Related]
17. Prepubic inflammatory liposarcoma presenting as urosepsis.
Khattar M; Singh P; Nayak B; Khan SA; Kumar VS
Indian J Urol; 2023; 39(1):67-69. PubMed ID: 36824117
[TBL] [Abstract][Full Text] [Related]
18. Effects of cisplatin in combination with hyperthermia on biological characteristics of retroperitoneal liposarcoma.
Miao CL; Hanif S; Zhang L; Chen XB; Huang M; Liu SB; Luo CH
Chin Med J (Engl); 2020 Dec; 134(9):1110-1112. PubMed ID: 33323818
[No Abstract] [Full Text] [Related]
19. Correction to: Analysis of Differentiation Changes and Outcomes at Time of First Recurrence of Retroperitoneal Liposarcoma by Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG).
Nessim C; Raut CP; Callegaro D; Barretta F; Miceli R; Fairweather M; Blay JY; Strauss D; Rutkowski P; Ahuja N; Gonzalez R; Grignani G; Quagliuolo V; Stoeckle E; Lahat G; De Paoli A; Pillarisetty VG; Canter RJ; Mullen JT; Pennacchioli E; van Houdt W; Swallow CJ; Schrage Y; Cardona K; Fiore M; Gronchi A; Bagaria SP
Ann Surg Oncol; 2022 Mar; ():. PubMed ID: 35307808
[No Abstract] [Full Text] [Related]
20. Retroperitoneal Liposarcoma in a Woman With Neurofibromatosis Type 1.
Bou Boluda L; Sabater Abad J; Quecedo Estébanez E; Jiménez Sánchez AI
Actas Dermosifiliogr (Engl Ed); 2020 Dec; ():. PubMed ID: 33307005
[No Abstract] [Full Text] [Related]
[Next] [New Search]
